लखनऊ (21 नवंबर, 2021) सदी के सबसे बड़े संकट कोरोनावायरस ने जब पूरे दुनिया में कहर बरपाया तब भारत में इस संकट से निपटने में आयुर्वेद उम्मीद की किरण बनकर उभरा। भारत के स्वास्थ्य सेवा में इस अंतर को विश्व ने भी महसूस किया।
लखनऊ में रविवार को निरोगस्ट्रीट द्वारा आयोजित चिकित्सकों की परिचर्चा में ये बात उभर कर सामने आयी। इसमें 'भविष्य के हेल्थकेयर सिस्टम में आयुर्वेद की भूमिका' विषय पर देश के जाने-माने चिकित्सकों ने अपनी राय रखी।
इस मौके पर उत्तरप्रदेश आयुष विभाग के सेवानिवृत वरिष्ठ चिकित्सा अधिकारी (आयुर्वेद पंचकर्म, योग और सेल्फ डेवलप रिलैक्सेशन थेरेपी के विशेषज्ञ) डॉ. देवेश कुमार श्रीवास्तव ने ग्लोबल हेल्थकेयर प्लेटफॉर्म में आयुर्वेद हेल्थकेयर की उपयोगिता पर अपनी बात रखी।
डॉ. देवेश कुमार श्रीवास्तव ने अपने वक्तव्य में कहा कि आयुर्वेद में वैश्विक स्वास्थ्य चुनौतियों से निपटने की जबरदस्त क्षमता है और इसी कारण भविष्य में यह विश्व की स्वास्थ्य सेवाओं में अग्रणी भूमिका निभा सकता है। कोरोनावायरस की वैश्विक आपदा के समय आयुर्वेद ने अपनी इसी क्षमता को प्रमाणित किया और वैश्विक स्तर पर इसे स्वीकार भी किया गया। भविष्य की किसी भी स्वास्थ्य चुनौतियों का सामना करने में आयुर्वेद पूरी तरह से सक्षम है। योग्य आयुर्वेद चिकित्सकों और आयुर्वेदाचार्यों के निर्देशन में साक्ष्य आधारित उपचार और थेरेपी व प्रमाणिक आयुर्वेद की दवाइयों के माध्यम से असाध्य से असाध्य रोगों का बेहतर इलाज करने में आयुर्वेद सक्षम है।
कार्यक्रम में शहर के 50 से अधिक चिकित्सकों और आयुर्वेद चिकित्सा से जुड़े लोगों ने भाग लिया जो इस कार्यक्रम की सफलता की कहानी खुद-ब-खुद बयान करती है। देश के सबसे बड़े आयुर्वेद चिकित्सकों के प्लेटफॉर्म 'निरोगस्ट्रीट' द्वारा इस कार्यक्रम का आयोजन किया गया था। गौरतलब है कि आयुर्वेद के विविध विषयों को लेकर निरोगस्ट्रीट द्वारा इस तरह के कार्यक्रम अलग-अलग शहरों में लगातार आयोजित किये जा रहे हैं।
यह भी पढ़े► आयुष मंत्रालय द्वारा एएसयू एंड एच दवाओं के नियामकों और निर्माताओं के लिए प्रशिक्षण सत्र
To make regulators and manufacturers conversant with practical aspects of enforcement and manufacturing issues of Ayurveda, Siddha, Unani and Homeopathy (ASU&H) drugs, the Ministry of Ayush organised a two-day training programme on Thursday.
This is the first of the five training sessions to be organised by the drug policy section of the ministry, over a period three months.
Held at Regional Ayurveda Research Institute, Mandi, Himachal Pradesh for the northern zone, the training session was attended by 40 delegates from Himachal Pradesh, Uttarakhand, Punjab, Chandigarh, Ladakh, Jammu and Kashmir and Haryana.
The programme covers existing regulatory provisions, GMP, WHO-GMP, DTL, testing of ASU&H drugs, schemes for Industry and State drug control framework. It’s a two way interactive programme where the centre, state and stakeholders meet for hand holding and encouragement of the work being done with the target of quality AYUSH medicines.
According to ministry officials, the purpose of the training session is to bring the clarity about the regulations among the ASU&H drug regulators and ASU&H drug industry personnel at a common platform. Each State/UT amongst the AYUSH Drug Regulators, Industry personnel and other stakeholders nominate their representatives to attend the training session.
The training sessions are being organised by the drug policy section of the Ministry in collaboration with Central Council for Research in Ayurvedic Sciences and various National Institutes.
Read More► Ministry Sets Up Expert Group to Examine Advisory Against Using Ashwagandha Leaves in ASU Drugs
New York- Covid-19 infection during pregnancy leads to distinct immune changes in mothers and babies, according to a study.
The researchers found that Covid-19 dysregulates maternal immune response, with different immune signatures between mothers with asymptomatic and severe disease.
"We know that pregnancy increases maternal risk for Covid-19, but relatively little is known about the long-term consequences of in-utero exposure for infants," said Jae Jung, Director of the Cleveland Clinic Global Center for Pathogen & Human Health Research.
The study highlights "how important it will be for long-term follow-up after pregnancy to catch and hopefully prevent any unforeseen long-term health conditions related to prenatal infection,"Jung added.
For the study, published in the journal Cell Reports Medicine, the team involved 93 mothers with Covid-19 and 45 of their infant children who were exposed to SARS-CoV-2, the virus that causes Covid-19.
The research team studied immune profiles for more than 1,400 cytokines and other inflammatory proteins collected from peripheral and cord blood samples.
The researchers compared maternal blood specimens collected close to the initial detection of SARS-CoV-2 and at different time points throughout pregnancy and delivery.
They found that compared to mild or moderate disease, pregnant women with severe Covid-19 exhibited significantly more inflammation and elevated levels of a protein called IFNL1 (interferon lambda 1) and the receptor it binds with, IFNLR1, which plays a critical role in protecting against viruses.
"This increase in interferon lambda signaling may help explain why we see relatively little direct transmission of Covid-19 between mother and baby during the period right before or after birth -- what we call vertical transmission," explained Suan-Sin (Jolin) Foo, a research associate in Dr. Jung's lab and co-first author on the paper.
Despite the lack of evidence for robust vertical transmission, the researchers found that SARS-CoV-2 infection alters maternal immunity at delivery and that gestational SARS-CoV-2 exposure alters infant immunity at birth.
At delivery, the women exhibited dysregulated levels of several cytokines that are associated with pregnancy complications, including MMP7, MDK, ESM1, BGN and CD209.
Among infants, prenatal exposure induced the expression of cytokines related to T cells, which are a type of immune cell involved in recognising and attacking specific antigens.
The majority of births within the cohort were healthy, but there was a high incidence of some complications, including preeclampsia and foetal growth restriction.
More research will be necessary to understand the extent to which the observed immune changes are related to these clinical outcomes, the team said.
Read More► How Covid-19 Exposed Vulnerability in People With Diabetes
Did you know that over 40-year-olds might lose up to 8 per cent of their muscle mass every decade? After the age of 70, the pace of decrease may double.
Sarcopenia, or advanced muscle loss, affects roughly one-third of persons over the age of 50. Muscles are crucial for organ function, skin health, immunity and metabolism, as well as for common physical acts like picking things up, reaching for something, opening a jar or getting out of a chair. To put it another way, keeping muscle mass as you become older is critical to living a happy and healthy life.
"Muscle loss is an ageing factor that is rarely discussed, and people accept its signs, such as a loss of strength and energy, as a natural part of ageing," says Ganesh Kadhe, Associate Director Medical and Scientific Affairs at Abbott Nutrition.
"However, muscle fitness can often predict how we will age and remain active and independent."
The good news is that you may assist, prevent or delay muscle loss by taking the appropriate precautions. While muscle loss is unavoidable as we age, it does not have to be.
To stay strong as you age, start following the tips below to fuel and keep muscles fit for years to come!
1. Engage in regular exercise, including resistance training, to maintain muscles and strength.
2. Eat good source of protein from lean meats, eggs and beans; aim for 25-30 grams of protein at every meal.
3. Choose a balanced diet full of veggies, fruits, whole grains, proteins, healthy fats and key vitamins and minerals like calcium and vitamin D.
4. Consider taking other muscle health ingredients, like HMB.
5. Talk to your healthcare provider about nutrition, especially if you are ill, hospitalised or recovering from surgery, to manage illness-related muscle loss.
Read More► 6 Bone Strengthening Yoga Poses for Osteoporosis
The rise in air pollution, coupled with lousy lifestyle habits, is causing a spike in respiratory diseases. According to a Lancet report, the contribution of chronic respiratory diseases in India increased from 4.5 per cent in 1990 to 6.4 per cent in 2016. With respiratory issues on the rise, there is an increased demand for natural solutions to treat such issues. Instead of conventional medicine, people are turning to alternative medical therapies to find cures for ailments.
Common Lung Disorders
Bronchitis is a health condition that causes inflammation in the airways of the lungs. This leads to narrowing of the air pathways and excess mucus causes wheezing, coughing and difficulty breathing. It is a chronic condition that interferes seriously with daily life.
Chronic Obstructive Pulmonary Disease (COPD)
It is a chronic inflammatory lung disease that obstructs the airflow to the lungs. Symptoms of COPD include breathing difficulty, mucus (sputum) production, coughing, and wheezing. It can result from long-term exposure to irritating gases or particulate matter, most often from cigarette smoke. Those affected by COPD are at an increased risk of developing lung cancer, heart disease, and a variety of other conditions.
This is another variation of COPD. Bronchitis causes a similar build-up of mucus that can cause inflammation and coughing. The lungs' airways are constantly inflamed as chronic bronchitis often lasts for months on end. Symptoms of chronic bronchitis include incessant coughing, whistling sounds while breathing, wheezing and a tightening of the chest.
It is said that the cure for all ailments is available the natural way. Here are some of the alternative medicine approaches to treat respiratory disorders.
Alternative Medicinal Approaches to Treat Respiratory Disorders
Asthma is one of the most common lung diseases. One of the primary causes of asthma is allergies, which often result from the food consumed. It is crucial, therefore, to first prepare a diet that is suitable for an individual. Often, dairy products, meats, and certain nuts can increase the production of mucus.
Foods like these must be avoided. Also, antioxidants can prevent damage resulting from chronic obstructive pulmonary disease. Diet is important in this regard, as fruits and vegetables high in Vitamins A, C, and E can improve the condition of COPD patients.
Yoga and Exercise
Treatment of lung disorders often involves the use of the lungs to promote healthy breathing habits. Exercises like cycling, swimming, yoga etc. that create a need for full capacity breathing are of great importance. Exercising the diaphragm is important and simple activities can go a long way in the treatment of the same.
Pranayama, the practise of controlled breathing, is an integral part of alternative treatment for people suffering from respiratory issues. This extensive breathing practice helps to expand the lungs and improve the capacity of the lungs, which helps an individual breathe more freely.
Nasal irrigation systems like JalNeti using a Neti pot can help to rinse the sinuses, which may provide some relief from symptoms of respiratory allergies.
The traditional Chinese practice of acupuncture involves inserting thin needles into the skin to stimulate certain parts of the body. According to a study published in the journal Annals of Allergy, Asthma and Immunology, people with allergic rhinitis who were given acupuncture treatments twice a week for eight weeks had fewer symptoms than those administered placebo.
It is important to remember that no one complementary or alternative therapy works well for everyone with respiratory issues. Therefore, a proper assessment is done before deciding on the approach to the treatment plan. For those considering alternative medicine for their respiratory problems, it is recommended to speak to an expert first and discuss the approach that may work best. (Vinoda Kumary, Deputy Chief Medical Officer, Jindal Naturecure Institute)
Read More► Heartfulness Meditation Helps in Reducing Stress, Reveals Study
आयुष मंत्रालयाने यासाठी तज्ञ गटाची स्थापना करून एएसयू (आयुर्वेद, सिद्ध आणि युनानी) औषधांमध्ये अश्वगंधा (विथानिया सोम्निफेरल) पानांच्या वापराशी संबंधित प्रकरणाची पुन्हा तपासणी करण्याचा निर्णय घेतला आहे.
यापूर्वी, मंत्रालयाने ASU औषधांमध्ये अश्वगंधाच्या पानांच्या वापराविरोधात मार्गदर्शक तत्वे जारी केली होती.
आयुष मंत्रालयाने अश्वगंधा पानांचा वापर प्रतिबंधित केल्याच्या पार्श्वभूमीवर एएसयू औषध निर्मण उद्योगांच्या भागीदारांकडून निवेदने प्राप्त झाली होती.
तसेच, आयुष मंत्रालयाने हितधारकांना एएसयू उत्पादनांमध्ये अश्वगंधाच्या पानांच्या वापराबाबत समस्यांवर चर्चा करण्यासाठी आमंत्रित केले होते. या चर्चेच्या आधारे, मंत्रालयाने तज्ज्ञ गट स्थापन करून अश्वगंधा (विथानिया सोम्निफेरा) पाने वापरण्यापासून परावृत्त करण्यासाठी औषध उत्पादकांना जारी केलेल्या मार्गदर्शक तत्वे पुन्हा तपासून पाहण्याचा निर्णय घेतला आहे.
वैज्ञानिक पुराव्याच्या आधारे एएसयू उत्पादनांमध्ये अश्वगंधाची पाने/अश्वगंधाच्या पंचांगाच्या वापराबाबत तज्ञ गट सरकारला योग्य शिफारसी करेल.
पुढे वाचा► आयुष-64 ची मागणी आता सहज पूर्ण होणार; सीसीआरएएस ने 46 कंपन्यांना तंत्रज्ञान हस्तांतरित केले